12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Glycobiosciences Inc., Hi-Tech Pharmacal sales and marketing update

Glycobiosciences granted Hi-Tech exclusive, U.S. commercialization rights to a hyaluronic acid and emollient-based topical wound gel. Hi-Tech will immediately...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >